Healthcare and Medical Device

The global oligonucleotide synthesis market is booming, projected to grow from $8.8 billion in 2024 to a staggering $19.7 billion by 2029 at a compound annual growth rate (CAGR) of 17.5%. This meteoric rise is fueled by several key drivers and emerging opportunities in the industry. A major catalyst is the increasing use of synthesized oligonucleotides in therapeutic and diagnostic applications. Oligonucleotide-based drugs hold immense potential for treating a wide range of neurological and rare diseases, leading to a surge in regulatory approvals. Additionally, oligonucleotides play a crucial role in genetic testing, molecular diagnostics, microarrays, and gene therapy, driving demand for accurate and sensitive detection and quantification tools. Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=200829350 While the market is thriving, it faces challenges, such as complexities associated with controlling oligonucleotide length and minimizing impuri...

According to a new report by MarketsandMarkets™ –  Oligonucleotide Synthesis Market  in terms of revenue was estimated to be worth $8.8 billion in 2024 and is poised to reach $19.7 billion by 2029, growing at a CAGR of 17.5% from 2024 to 2029. One of the key factors driving the market growth is the growing acceptance of alternate therapies such as oligonucleotide-based therapies for the treatment of neurological and rare The incorporation of synthesized oligonucleotides to treat various diseases also supports market growth. Download an Illustrative overview:  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=200829350 Probes are an important subsegment in the market for synthesized oligonucleotides. The segment accounted for the second-largest market share of the synthesized oligonucleotide market. This is due to high specificity and sensitivity of probes allowing their use in genetic research, pathogen detection, clinical diagnostics, and the study of gene expressi...